Thrombocytopenia induced by the histone deacetylase inhibitor abexinostat involves p53-dependent and -independent mechanisms

Abexinostat is a pan histone deacetylase inhibitor (HDACi) that demonstrates efficacy in malignancy treatment. Like other HDACi, this drug induces a profound thrombocytopenia whose mechanism is only partially understood. We have analyzed its effect at doses reached in patient plasma on in vitro mega...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Ali, A, Bluteau, O, Messaoudi, K, Palazzo, A, Boukour, S, Lordier, L, Lecluse, Y, Rameau, P, Kraus-Berthier, L, Jacquet-Bescond, A, Lelièvre, H, Depil, S, Dessen, P, Solary, E, Raslova, H, Vainchenker, W, Plo, I, Debili, N
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group 2013
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3730430/
https://ncbi.nlm.nih.gov/pubmed/23887629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2013.260
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk